RESUMO Introdução: A anemia é frequente em pacientes submetidos à terapia substitutiva para insuficiência renal. A anemia nos períodos pré e pós-transplante pode estar relacionada aos desfechos do transplante renal. Portanto, o presente estudo buscou avaliar a relação entre anemia, função retardada do enxerto (FRE), disfunção crônica do enxerto renal (DCE) e óbito por qualquer causa após transplante renal de doador falecido. Métodos: Este foi um estudo retrospectivo com 206 pacientes transplantados renais de doadores falecidos. Analisamos dados demográficos de doadores falecidos e pacientes transplantados renais. Além disso, comparamos parâmetros bioquímicos, status de anemia e medicamentos entre os grupos FRE e não-FRE. Posteriormente, realizamos uma análise multivariada. Também avaliamos desfechos, como DCE em um ano e óbito em dez anos. Resultados: Observamos menor frequência de concentração de hemoglobina (Hb) pré-transplante, mas maior frequência de creatinina sérica do doador e transfusão de hemácias no período de uma semana após o transplante no grupo FRE. Além disso, houve associação independente entre a concentração de Hb antes do transplante e a FRE [OR 0,252; IC 95%: 0,159–0,401; p < 0,001]. Houve também associação entre a concentração de Hb após seis meses de transplante renal e ambos, DCE [OR 0,798; IC95%: 0,687–0,926; p = 0,003] e óbito por qualquer causa. Conclusão: Encontrou-se uma associação entre anemia pré-transplante e FRE e entre anemia seis meses após o transplante e ambos, DCE e óbito por qualquer causa. Assim, a anemia antes ou após o transplante afeta os desfechos de pacientes que foram submetidos a transplante renal de doador falecido. Introdução póstransplante pós Portanto FRE, , (FRE) (DCE falecido Métodos 20 disso bioquímicos nãoFRE. nãoFRE não não-FRE Posteriormente multivariada anos Resultados (Hb prétransplante, prétransplante transplante, OR 0,252 0252 0 252 95% 95 0,159–0,401 01590401 159 401 0,001. 0001 0,001 . 001 0,001] ambos 0,798 0798 798 IC95% IC95 0,687–0,926 06870926 687 926 0,003 0003 003 Conclusão Encontrouse Encontrou se Assim (FRE 2 0,25 025 25 9 0,159–0,40 0159040 15 40 000 0,00 00 0,79 079 79 IC9 0,687–0,92 0687092 68 92 0,2 02 0,159–0,4 015904 1 4 0,0 0,7 07 7 0,687–0,9 068709 6 0, 0,159–0, 01590 0,687–0, 06870 0,159–0 0159 0,687–0 0687 0,159– 015 0,687– 068 0,159 01 0,687 06 0,15 0,68 0,1 0,6

ABSTRACT Introduction: Anemia is frequent in patients undergoing replacement therapy for kidney failure. Anemia in the pre- and post-transplantation period might be related to kidney transplant outcomes. The current study therefore sought to assess the relationship between anemia, delayed allograft function (DGF), chronic kidney allograft dysfunction (CAD), and death from any cause following kidney transplantation from a deceased donor. Methods: This was a retrospective study with 206 kidney transplant patients of deceased donors. We analyzed deceased donors’ and kidney transplant patients’ demographic data. Moreover, we compared biochemical parameters, anemia status, and medicines between DGF and non-DGF groups. Afterward, we performed a multivariate analysis. We also evaluated outcomes, such as CAD within one year and death in ten years. Results: We observed a lower frequency of pre-transplant hemoglobin concentration (Hb) but higher frequency of donor-serum creatinine and red blood transfusion within one week after transplantation in the group with DGF. In addition, there was an independent association between Hb concentration before transplantation and DGF [OR 0.252, 95%CI: 0.159–0.401; p < 0.001]. There was also an association between Hb concentration after six months of kidney transplantation and both CAD [OR 0.798, 95% CI: 0.687–0.926; p = 0.003] and death from any cause. Conclusion: An association was found between pre-transplantation anemia and DGF and between anemia six months after transplantation and both CAD and death by any cause. Thus, anemia before or after transplantation affects the outcomes for patients who have undergone kidney transplantation from a deceased donor. Introduction failure pre posttransplantation post DGF, , (DGF) CAD, (CAD) donor Methods 20 donors data Moreover parameters status nonDGF non groups Afterward analysis years Results pretransplant (Hb donorserum serum addition OR 0252 0 252 0.252 95%CI 95CI CI 95 0.159–0.401 01590401 159 401 0.001. 0001 0.001 . 001 0.001] 0798 798 0.798 0.687–0.926 06870926 687 926 0.003 0003 003 Conclusion pretransplantation Thus (DGF (CAD 2 025 25 0.25 9 0.159–0.40 0159040 15 40 000 0.00 00 079 79 0.79 0.687–0.92 0687092 68 92 02 0.2 0.159–0.4 015904 1 4 0.0 07 7 0.7 0.687–0.9 068709 6 0. 0.159–0. 01590 0.687–0. 06870 0.159–0 0159 0.687–0 0687 0.159– 015 0.687– 068 0.159 01 0.687 06 0.15 0.68 0.1 0.6

Resumo Antecedentes: Lesão renal aguda (LRA) é uma complicação frequente da doença do coronavírus-19 (COVID-19). Desta forma, decidimos realizar uma revisão sistemática e uma metanálise com dados da literatura para relacionar o desenvolvimento de LRA associada à COVID-19 com comorbidades, medicamentos e o impacto da ventilação mecânica. Métodos: Realizamos uma revisão sistemática usando a escala de Newcastle-Ottawa e uma metanálise utilizando o programa R. Estudos relevantes foram pesquisados nos bancos de dados eletrônicos PubMed, Medline e SciELO. Foram utilizados filtros de pesquisa para incluir relatos após 2020 e estudos de coorte. Resultados: No total, foram identificados 1166 artigos, e foram incluídos 55 artigos escritos em língua inglesa com base no risco de viés. De todos os pacientes hospitalizados por COVID-19 apresentando LRA (n = 18029) classificados como Kidney Disease Improving Global Outcomes estágios 1 a 3, aproximadamente 18% necessitaram de ventilação mecânica e 39,2% foram a óbito. Cerca de 11,3% dos pacientes necessitaram de terapia renal substitutiva (TRS) e destes, 1093 foram a óbito e 321 necessitaram de TRS contínua. O óbito é mais frequente em indivíduos com LRA [OR 6,03; IC95%: 5,73-6,74; p<0,01]. Por fim, a ventilação mecânica é um fator agravante nas condições clínicas estudadas [OR 11,01; IC95%: 10,29-11,77; p<0,01]. Conclusão: A literatura atual indica a LRA como uma complicação importante na COVID-19. Neste contexto, observamos que comorbidades, como doença renal crônica e insuficiência cardíaca, estiveram mais relacionadas ao desenvolvimento de LRA. Além disso, a ventilação mecânica foi vista como um fator agravante neste cenário. Antecedentes (LRA coronavírus19 coronavírus 19 coronavírus-1 COVID19. COVID19 COVID . (COVID-19) forma COVID-1 comorbidades Métodos NewcastleOttawa Newcastle Ottawa R PubMed SciELO 202 coorte Resultados total 116 5 viés n 18029 3 18 392 39 2 39,2 113 11 11,3 (TRS destes 109 32 contínua OR 6,03 603 6 03 IC95% IC95 IC 5,736,74 573674 5,73 6,74 73 74 5,73-6,74 p<0,01. p001 p p<0,01 0 01 p<0,01] fim 11,01 1101 10,2911,77 10291177 10,29 11,77 10 29 77 10,29-11,77 Conclusão 19. contexto cardíaca disso cenário coronavírus1 coronavírus- COVID1 (COVID-19 COVID- 20 1802 39, 11, 6,0 60 IC9 736 5,736,7 57367 573 5,7 674 6,7 7 5,73-6,7 p00 p<0,0 11,0 110 2911 10,2911,7 1029117 1029 10,2 1177 11,7 10,29-11,7 (COVID-1 180 6, 5,736, 5736 57 5, 67 5,73-6, p0 p<0, 291 10,2911, 102911 102 10, 117 10,29-11, (COVID- 5,736 5,73-6 p<0 10,2911 10291 10,29-11 (COVID 5,73- p< 10,291 10,29-1 10,29-

Abstract Background: Acute kidney injury (AKI) is a frequent complication of coronavirus-19 disease (COVID-19). Therefore, we decided to perform a systematic review and meta-analysis with data from the literature to relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation. Methods: We performed a systematic review using the Newcastle-Ottawa scale and a meta-analysis using the R program. Relevant studies were searched in the PubMed, Medline, and SciELO electronic databases. Search filters were used to include reports after 2020 and cohort studies. Results: In total, 1166 articles were identified and 55 English-written articles were included based on the risk of bias. Of all COVID-19-hospitalized patients presenting with AKI (n = 18029) classified as Kidney Disease Improving Global Outcomes stage 1 to 3, approximately 18% required mechanical ventilation and 39.2 % died. Around 11.3% of the patients required kidney replacement therapy (KRT) and of these, 1093 died and 321 required continuous KRT. Death is more frequent in individuals with AKI [OR 6.03, 95%CI: 5.73-6.74; p<0.01]. Finally, mechanical ventilation is an aggravating factor in the clinical conditions studied [OR 11.01, 95%CI: 10.29-11.77; p<0.01]. Conclusion: Current literature indicates AKI as an important complication in COVID-19. In this context, we observed that comorbidities, such as chronic kidney disease and heart failure, were more related to the development of AKI. In addition, mechanical ventilation was seen as an aggravating factor in this scenario. Background (AKI coronavirus19 coronavirus 19 coronavirus-1 COVID19. COVID19 COVID . (COVID-19) Therefore metaanalysis meta analysis COVID-1 associatedAKI associated comorbidities medications Methods NewcastleOttawa Newcastle Ottawa program PubMed Medline databases 202 Results total 116 5 Englishwritten English written bias COVID19hospitalized COVIDhospitalized hospitalized n 18029 3 18 392 39 2 39. 113 11 11.3 KRT (KRT these 109 32 OR 603 6 03 6.03 95%CI 95CI CI 95 5.736.74 573674 5.73 6.74 73 74 5.73-6.74 p<0.01. p001 p p<0.01 0 01 p<0.01] Finally 1101 11.01 10.2911.77 10291177 10.29 11.77 10 29 77 10.29-11.77 Conclusion 19. context failure addition scenario coronavirus1 coronavirus- COVID1 (COVID-19 COVID- 20 1802 11. 60 6.0 9 736 5.736.7 57367 573 5.7 674 6.7 7 5.73-6.7 p00 p<0.0 110 11.0 2911 10.2911.7 1029117 1029 10.2 1177 11.7 10.29-11.7 (COVID-1 180 6. 5.736. 5736 57 5. 67 5.73-6. p0 p<0. 291 10.2911. 102911 102 10. 117 10.29-11. (COVID- 5.736 5.73-6 p<0 10.2911 10291 10.29-11 (COVID 5.73- p< 10.291 10.29-1 10.29-

ABSTRACT Objective The objective of the present study is to evaluate the association of red blood cell distribution width with acute kidney injury in sepsis. Methods This is a retrospective study of 849 critically ill patients with sepsis in intensive care unit. Demographic data, renal function, inflammation, complete blood count, and acid-base parameters were compared between acute kidney injury and non-acute kidney injury groups. Therefore, a multivariate analysis was performed to observe independent predictive factors. Results Comparatively, higher levels of C-reactive protein, lactate, red blood cell distribution width, and Simplified Acute Physiology Score 3 were found in the acute kidney injury group. The study showed a higher frequency of women, hemoglobin (Hgb) concentration, platelets, bicarbonate and PaO2/FiO2 ratio in the non-acute kidney injury group. In addition, there was an independent association of comorbidity-chronic kidney disease [OR 3.549, 95%CI: 1.627-7.743; p<0.001], urea [OR 1.047, 95%CI: 1.036-1.058; p<0.001] and RDW [OR 1.158, 95%CI: 1.045-1.283; p=0.005] with acute kidney injury in sepsis patients. Conclusion As an elective risk factor, red blood cell distribution width was independently associated with sepsis-related acute kidney injury. Thus, red blood cell distribution width acts like a predictive factor for sepsis-induced acute kidney injury in intensive care unit admission.

OBJECTIVES: Intestinal obstruction has a high mortality rate when therapeutic treatment is delayed. Resuscitation in intestinal obstruction requires a large volume of fluid, and fluid combinations have been studied. Therefore, we evaluated the effects of hypertonic saline solution (HS) with pentoxifylline (PTX) on apoptosis, oxidative stress and survival rate. METHODS: Wistar rats were subjected to intestinal obstruction and ischemia through a closed loop ligation of the terminal ileum and its vessels. After 24 hours, the necrotic bowel segment was resected, and the animals were randomized into four groups according to the following resuscitation strategies: Ringer's lactate solution (RL) (RL-32 ml/kg); RL+PTX (25 mg/kg); HS+PTX (HS, 7.5%, 4 ml/kg), and no resuscitation (IO-intestinal obstruction and ischemia). Euthanasia was performed 3 hours after resuscitation to obtain kidney and intestine samples. A malondialdehyde (MDA) assay was performed to evaluate oxidative stress, and histochemical analyses (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling [TUNEL], Bcl-2 and Bax) were conducted to evaluate kidney apoptosis. Survival was analyzed with another series of animals that were observed for 15 days. RESULTS: PTX in combination with RL or HS reduced the MDA levels (nmol/mg of protein), as follows: kidney IO=0.42; RL=0.49; RL+PTX=0.31; HS+PTX=0.34 (p<0.05); intestine: IO=0.42; RL=0.48; RL+PTX=0.29; HS+PTX=0.26 (p<0.05). The number of labeled cells for TUNEL and Bax was lower in the HS+PTX group than in the other groups (p<0.05). The Bax/Bcl-2 ratio was lower in the HS+PTX group than in the other groups (p<0.05). The survival rate on the 15th day was higher in the HS+PTX group (77%) than in the RL+PTX group (11%). CONCLUSION: PTX in combination with HS enhanced survival and attenuated oxidative stress and apoptosis. However, when combined with RL, PTX did not reduce apoptosis or mortality.